Federal Register / Vol. 80, No. 55 / Monday, March 23, 2015 / Notices 15213 

information concerning carrier-installed 

wiring on the customer’s side of the 

demarcation point, including copies of 

existing schematic diagrams and service 

records, shall be provided by the 

telephone company upon request of the 

building owner or agent thereof. The 

provider of wireline 

telecommunications services may 

charge the building owner a reasonable 

fee for this service, which shall not 

exceed the cost involved in locating and 

copying the documents. In the 

alternative, the provider may make 

these documents available for review 

and copying by the building owner or 

his agent. In this case, the wireline 

telecommunications carrier may charge 

a reasonable fee, which shall not exceed 

the cost involved in making the 

documents available, and may also 

require the building owner or his agent 

to pay a deposit to guarantee the 

documents’ return. The information is 

needed so that building owners may 

choose to contract with an installer of 

their choice on inside wiring 

maintenance and installation services to 

modify existing wiring or assist with the 

installation of additional inside wiring. 

Federal Communications Commission. 

Marlene H. Dortch, 

Secretary, Office of the Secretary, Office of 

the Managing Director. 

[FR Doc. 2015–06509 Filed 3–20–15; 8:45 am] 

BILLING CODE 6712–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than April 17, 2015. 

A. Federal Reserve Bank of Atlanta 

(Chapelle Davis, Assistant Vice 

President) 1000 Peachtree Street NE., 

Atlanta, Georgia 30309: 

1. Sunshine Bancorp, Inc., Plant City, 

Florida; to become a bank holding 

company by acquiring 100 percent of 

the voting shares of Community 

Southern Holdings, Inc., and its 

subsidiary, Community Southern Bank, 

both of Lakeland, Florida. 

Board of Governors of the Federal Reserve 

System, March 18, 2015. 

Michael J. Lewandowski, 

Associate Secretary of the Board. 

[FR Doc. 2015–06560 Filed 3–20–15; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire shares of a bank 

or bank holding company. The factors 

that are considered in acting on the 

notices are set forth in paragraph 7 of 

the Act (12 U.S.C. 1817(j)(7)). 

The notices are available for 

immediate inspection at the Federal 

Reserve Bank indicated. The notices 

also will be available for inspection at 

the offices of the Board of Governors. 

Interested persons may express their 

views in writing to the Reserve Bank 

indicated for that notice or to the offices 

of the Board of Governors. Comments 

must be received not later than April 7, 

2015. 

A. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. John E. Boyer, individually and as 

trustee of the Merlyn Boyer Irrevocable 

GST Trust, the John E. Boyer 

Grandchildren’s Trust, the Emily Ryan 

Boyer Irrevocable Trust, and the Jack 

Eric Boyer Irrevocable Trust, all of 

Kingman, Kansas; and Emily Boyer, 

Kingman, Kansas, as a member of The 

Boyer Family Group; to retain voting 

shares of KANZA Financial 

Corporation, parent of KANZA Bank, 

both in Kingman, Kansas. 

Board of Governors of the Federal Reserve 

System, March 18, 2015. 

Michael J. Lewandowski, 

Associate Secretary of the Board. 

[FR Doc. 2015–06561 Filed 3–20–15; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Cancer 

Institute Special Emphasis Panel, March 

26, 2015 6:30 p.m. to March 27, 2015, 

4 p.m., Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852 which was 

published in the Federal Register on 

February 17, 2015, 80FR8331. 

The meeting notice is amended to 

change the date and start time to be held 

on March 27, 2015 at 7:30 a.m. The 

meeting is closed to the public. 

Dated: March 17, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–06478 Filed 3–20–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: 

Voluntary Relinquishment From PSO 

Services Group 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), Department of 

Health and Human Services (HHS). 

ACTION: Notice of Delisting. 

SUMMARY: The Patient Safety and 

Quality Improvement Act of 2005, 42 

U.S.C. 299b–21 to b–26, (Patient Safety 

Act) and the related Patient Safety and 

Quality Improvement Final Rule, 42 

CFR part 3 (Patient Safety Rule), 

published in the Federal Register on 

November 21, 2008 (73 FR 70732– 

70814), provide for the formation of 

Patient Safety Organizations (PSOs), 

which collect, aggregate, and analyze 

confidential information regarding the 

quality and safety of healthcare 

mstockstill on DSK4VPTVN1PROD with NOTICES

15214 Federal Register / Vol. 80, No. 55 / Monday, March 23, 2015 / Notices 

delivery. The Patient Safety Rule 

authorizes AHRQ, on behalf of the 

Secretary of HHS, to list as a PSO an 

entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ by 

the Secretary if it is found to no longer 

meet the requirements of the Patient 

Safety Act and Patient Safety Rule, 

when a PSO chooses to voluntarily 

relinquish its status as a PSO for any 

reason, or when a PSO’s listing expires. 

AHRQ has accepted a notification of 

voluntary relinquishment from PSO 

Services Group of its status as a PSO, 

and has delisted the PSO accordingly. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12:00 Midnight 

ET (2400) on January 5, 2015. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS Web site: http://

www.pso.AHRQ.gov/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Eileen Hogan, Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; Email: PSO@

AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act authorizes the 

listing of PSOs, which are entities or 

component organizations whose 

mission and primary activity are to 

conduct activities to improve patient 

safety and the quality of health care 

delivery. 

HHS issued the Patient Safety Rule to 

implement the Patient Safety Act. 

AHRQ administers the provisions of the 

Patient Safety Act and Patient Safety 

Rule relating to the listing and operation 

of PSOs. The Patient Safety Rule 

authorizes AHRQ to list as a PSO an 

entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ if 

it is found to no longer meet the 

requirements of the Patient Safety Act 

and Patient Safety Rule, when a PSO 

chooses to voluntarily relinquish its 

status as a PSO for any reason, or when 

a PSO’s listing expires. Section 3.108(d) 

of the Patient Safety Rule requires 

AHRQ to provide public notice when it 

removes an organization from the list of 

federally approved PSOs. 

AHRQ has accepted a notification 

from PSO Services Group, PSO number 

P0028, to voluntarily relinquish its 

status as a PSO. Accordingly, PSO 

Services Group was delisted effective at 

12:00 Midnight ET (2400) on January 5, 

2015. 

PSO Services Group has patient safety 

work product (PSWP) in its possession. 

The PSO will meet the requirements of 

section 3.108(c)(2)(i) of the Patient 

Safety Rule regarding notification to 

providers that have reported to the PSO. 

In addition, according to sections 

3.108(c)(2)(ii) and 3.108(b)(3) of the 

Patient Safety Rule regarding 

disposition of PSWP, the PSO has 90 

days from the effective date of delisting 

and revocation to complete the 

disposition of PSWP that is currently in 

the PSO’s possession. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/

index.html. 

Dated: March 17, 2015. 

Sharon B. Arnold, 

Deputy Director, AHRQ. 

[FR Doc. 2015–06455 Filed 3–20–15; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0742] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Registration of 

Producers of Drugs and Listing of 

Drugs in Commercial Distribution 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the Agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal Agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the requirements for drug establishment 

registration and drug listing. 

DATES: Submit either electronic or 

written comments on the collection of 

information by May 22, 2015. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http://

www.regulations.gov. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA 305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: FDA 

PRA Staff, Office of Operations, Food 

and Drug Administration, 8455 

Colesville Rd., COLE–14526, Silver 

Spring, MD 20993–0002; PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA (44 U.S.C. 3501–3520), Federal 

Agencies must obtain approval from the 

Office of Management and Budget 

(OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ is defined 

in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes Agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA (44 

U.S.C. 3506(c)(2)(A)) requires Federal 

Agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information, 

including each proposed extension of an 

existing collection of information, 

before submitting the collection to OMB 

for approval. To comply with this 

requirement, FDA is publishing notice 

of the proposed collection of 

information set forth in this document. 

With respect to the following 

collection of information, FDA invites 

comments on these topics: (1) Whether 

the proposed collection of information 

is necessary for the proper performance 

of FDA’s functions, including whether 

the information will have practical 

utility; (2) the accuracy of FDA’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques, 

when appropriate, and other forms of 

information technology. 

Registration of Producers of Drugs and 

Listing of Drugs in Commercial 

Distribution—21 CFR Part 207 (OMB 

Control Number 0910–0045)—Extension 

Requirements for drug establishment 

registration and drug listing are set forth 

in section 510 of the Federal Food, 

Drug, and Cosmetic Act (the FD&C Act) 

(21 U.S.C. 360), section 351 of the 

Public Health Service Act (42 U.S.C. 

mstockstill on DSK4VPTVN1PROD with NOTICES